Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies

Cellebrite DI Ltd. (CLBT) announced that its cloud-based digital evidence management platform, Guardian, has achieved a PROTECTED classification level under the Infosec Registered Assessors Program (IRAP) in Australia. This milestone allows Australian government agencies to use Guardian for secure digital evidence collaboration. The assessment was conducted by CyberCX, an Australian Signals Directorate-endorsed IRAP assessor.

Original reporting
Published Sep 2, 2026, 2:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 2, 2026, 3:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cellebrite Guardian Completes IRAP Assessment: Achieves PROTECTED Level for Australian Government Agencies — source image
Decision brief

The 30-second read

$CLBTNeutralLow
01

Why it matters

The certification could open new government sales channels, but the immediate market impact is likely modest.

02

Market read

A niche regulatory win for a specialized tech firm; limited short‑term price effect.

03

What to watch

Potential competition from other vendors and the time needed for agencies to complete internal authorizations.

Relevance 4/10Novelty 4/10Timing: announcement today

Background

Cellebrite provides digital investigative solutions worldwide; the IRAP assessment is an Australian government security standard.

Company-level read

Ticker impact

$CLBTNeutralMedium confidence
Context

Cellebrite announced its Guardian platform passed the IRAP PROTECTED level assessment for Australian government agencies.

Expected impact

Modest upside if the market prices in new Australian contracts.

Evidence & confidence

The news is a first‑time disclosure of a security certification, but no immediate financial details or contract values were provided.

Market effects

May encourage other digital‑evidence vendors to seek similar certifications.

Supports Australian government procurement of cloud‑based forensic tools.

Limited to niche law‑enforcement technology market.

Counterpoint

Without disclosed contract values, the certification may not translate into material revenue.

Key entities

  • Cellebrite DI Ltd.

    Provider of digital investigative and intelligence solutions.

  • CyberCX

    Australian security assessor that performed the IRAP evaluation.

Related articles

$CLBTMedAI 8/10

Cellebrite (CLBT) Q2 2026 Earnings Call Transcript

Cellebrite (CLBT) announced Shiv Ramji as its new CEO, replacing Tom Hogan. The company missed Q2 revenue expectations due to delayed large transactions and lower-than-expected ARR uplift. Despite this, they raised their full-year adjusted EBITDA target. Ramji outlined plans to improve sales execution and forecasting discipline. The company sees growth in new products and federal business, with a 25% increase in Defense and Intelligence ARR.

$CLBTMedAI 8/10

Why Cellebrite DI (CLBT) Is Down 30.4% After Cutting 2026 Outlook And Announcing CEO Transition

Cellebrite DI Ltd. reported half-year 2026 results and cut its full-year revenue outlook to US$555 million to US$561 million, implying 17% to 18% growth. The company also announced a CEO transition, with Shiven Ramji succeeding Thomas E. Hogan. The guidance reduction, weaker profitability, and delayed large government contracts contributed to a sharp stock drop.

$CLBTMedAI 8/10

Cellebrite DI Ltd. Q2 2026 Earnings Call Summary

Cellebrite DI Ltd. reported Q2 2026 results below expectations, citing delayed large transactions and procurement hurdles tied to foreign entity status. Full-year ARR guidance was cut to $550m–$560m, while adjusted EBITDA was raised to $153m–$159m. Management said Insights installed base reached 65% and Genesis launched with $400k ARR.